Program Schedule

18
Clinical Controversies in ID

Thursday, October 9, 2014: 8:30 AM-10:00 AM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV
Co-organized with the IDSA Clinical Affairs Committee

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the pros and cons of utilizing antiviral therapy for HCV
  • describe the pros and cons of a hospital employee career
  • outline the usefulness of contact precautions

Target Audience: Researchers, Public health practitioners, Pharmacists, Nurses, Members-in-training, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Hospital administrators, HIV specialists, HIV clinicians, Health care workers, Fellows, Epidemiologists, Clinicians, Academicians, HCV Specialists

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID

Interactive Moderators:  Patrick Joseph, MD, FIDSA, University of California, San Francisco and J Trees Ritter, DO, Central Coast Infectious Diseases Consultants

Presentations:
9:00 AM
50
Should ID Physicians be Hospital Employees
Russell Petrak, MD, FIDSA
9:15 AM
51
Should ID Physicians be Hospital Employees
Michael Buckley, MD, FIDSA
9:30 AM
52
Should Contact Precautions be Eliminated?
Michael Edmond, MD, MPH, MPA, FIDSA, FSHEA
9:45 AM
53
Should Contact Precautions be Eliminated?
David Pegues, MD, FIDSA, FSHEA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-095-L01-P

Disclosures:

P. Joseph, None

J. T. Ritter, None

D. Dieterich, Gilead : Consultant, Investigator and Scientific Advisor, Consulting fee and Research grant
BMS : Consultant and Investigator, Consulting fee and Research grant
ABBVIE : Consultant and Investigator, Consulting fee, Research grant and Speaker honorarium
JANSSEN : Consultant and Investigator, Consulting fee and Research grant
MERCK: Consultant and Investigator, Consulting fee and Research grant
IDENIX: Consultant, Consulting fee

S. Naggie, Abbvie: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
Achillion: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
BMS: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
Gillead: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
Vertex: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
IAS-USA: Collaborator and Member, Educational Activities or Lectures for this Company Generates Revenue for Duke
IDSA: Collaborator and Member, Educational Activities or Lectures for this Company Generates Revenue for Duke

R. Petrak, HHI Infusion: Board Member, Consulting fee

M. Buckley, None

M. Edmond, None

D. Pegues, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek